BiotechTube
Home/Matinas Biopharma/Evelyn D’An
ED

Evelyn D’An

Board Member, Audit Committee Chair

Matinas Biopharma

Therapeutic Areas

Infectious DiseaseInflammationOncology

Matinas Biopharma Pipeline

DrugIndicationPhase
MAT2203Invasive Fungal Infections (Candidiasis, Aspergillosis)Phase 2/3
LNC Platform DiscoveryOncology & InflammationDiscovery

Leadership Team at Matinas Biopharma

JD
Jerome D. Jabbour
Chief Executive Officer
KM
Keith Murphy
Board Member, Chair of Nominating and Governance Committee
EN
Edward Neugeboren
Board Member, Chair of Compensation Committee
RL
Robin L. Smith
Board Member
View full Matinas Biopharma profile